Search Results

You are looking at 141 - 150 of 465 items for :

  • Refine by Access: All x
Clear All
Full access

Waleed A. Hassen, Farrok A. Karsan, Farhat Abbas, Yasar Beduk, Ahmed El-Khodary, Marwan Ghosn, Jamal Khader, Raja Khauli, Danny M. Rabah, Ali Shamseddine, and Sandy Srinivas

are generally available, MRI has more limited availability. Treatment The definitive and palliative treatment of prostate cancer has multiple regional challenges. Definitive treatment typically involves either surgery or radiotherapy, and

Full access

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

Featured Updates to the NCCN Guidelines

Shaji K. Kumar, Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, Jason C. Chandler, Robert F. Cornell, Caitlin Costello, Yvonne Efebera, Matthew Faiman, Alfred Garfall, Kelly Godby, Leona Holmberg, Myo Htut, Carol Ann Huff, Yubin Kang, Ola Landgren, Ehsan Malek, Thomas Martin, James Omel, Noopur Raje, Douglas Sborov, Seema Singhal, Keith Stockerl-Goldstein, Carlyn Tan, Donna Weber, Alyse Johnson-Chilla, Jennifer Keller, and Rashmi Kumar

myeloma bone disease and stability of the spine. MRI is useful for discerning smoldering myeloma from MM. Because the disease burden in patients with smoldering myeloma is lower than in those with MM, imaging techniques with high sensitivity must be used

Full access

Presenter: Ronald S. Go

medical history and complete physical examination], we recommend a PET/CT scan because many of the lesions appear fibrotic and are infiltrative in nature,” Dr. Go commented. If PET/CT is unavailable, a whole-body CT scan, MRI of the brain, and bone scan

Full access

Wylie Burke and Nancy Press

screening with MRI—what are the data for patients at high risk? N Engl J Med 2004 ; 351 : 497 – 500 . 11. Nelson HD Huffman LH Fu R Harris EL . Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility

Full access

Lieke Gietelink, Michel W.J.M. Wouters, Pieter J. Tanis, Marion M. Deken, Martijn G. ten Berge, Rob A.E.M. Tollenaar, J. Han van Krieken, Mirre E. de Noo, and on behalf of the Dutch Surgical Colorectal Cancer Audit Group

Table 1 . A decrease occurred in unspecified clinical T classification ( P <.001). The use of MRI as preoperative imaging technique increased ( P <.001) and so did the percentage of patients who were preoperatively discussed in a multidisciplinary team

Full access

Bishal Gyawali and Saroj Niraula

Bayesian theorem. These rates are continually estimated and updated based on the decrease in tumor volume as assessed by MRI scans. Decrease in tumor volume on MRI scans is yet to be validated as a surrogate for achieving pCR. Thus, in I-SPY 2, a correlate

Full access

R. Lor Randall and William Gowski

. Philadelphia, PA : Lippincott-Raven ; 1996 . 17 Colyer RA Sallay P Buckwalter K . MRI assessment of chondroid matrix tumors . In: Limb Salvage: Current Trends–Proceedings of the 7th International Symposium. Singapore: International Symposium of

Full access

Nishant Patel, Adam C. Yopp, and Amit G. Singal

Most patients presented initially with an abnormal imaging study, with 219 (48%) presenting with abnormal abdominal ultrasound and 149 (33%) presenting with a mass on CT or MRI. AFP level was elevated in 135 patients (30%) including 67 whose

Full access

Lauren E. Kernochan and Rochelle L. Garcia

Edited by Kerrin G. Robinson

tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI . AJR Am J Roentgenol 2008 ; 191 : 278 – 283 . 13 Zelmanowicz A Hildesheim A Sherman ME . Evidence for a common etiology for endometrial carcinomas and malignant

Full access

Courtney Lawhn Heath, Laura J. Esserman, Robert R. Flavell, and Michelle E. Melisko

: evidence-based recommendations in initial staging . Tumour Biol 2017 ; 39 :1010428317728285. 10.1177/1010428317728285 29025377 4. Han S , Choi JY. Impact of 18F-FDG PET, PET/CT, and PET/MRI on staging and management as an initial staging